• 熔點： 208°C

• 沸點： 957.1°C at 760 mmHg

• 比旋光度： +47 (EtOH)

• 外觀： 白色結(jié)晶或粉末

• 溶解性： 溶于水，氯仿，乙醇，難溶于乙醚，甲醚，石油醚。

• 儲存條件： 2-8℃

• 注意：部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)威性，僅供客戶參考交流研究之用。

• 30. [2.8] Wenkui Zou et al."Unveiling the Mechanism of Compound Ku-Shen Injection in Liver Cancer Treatment through an Ingredient–Target Network Analysis."Genes.2024 Oct;15(10):1278

• 29. [IF=2.8] Yi Zhong et al."Oxymatrine induces apoptosis in non-small cell lung cancer cells by downregulating TRIM46."TOXICON".2024 Jun;244:107773

• 28. [IF=5.4] Bing Bing Gao et al."Beneficial effects of oxymatrine from Sophora flavescens on alleviating Ulcerative colitis by improving inflammation and ferroptosis."JOURNAL OF ETHNOPHARMACOLOGY".2024 Oct;332:118385

• 27. [IF=7.5] Di Lou et al."Oxymatrine alleviates high-fat diet/streptozotocin-induced non-alcoholic fatty liver disease in C57BL/6?J mice by modulating oxidative stress, inflammation and fibrosis."BIOMEDICINE & PHARMACOTHERAPY".2024 May;174:116491

• 26. [IF=5.4] Xinxin Wu et al."The therapeutic efficacy and mechanism action of Si Cao formula in the treatment of psoriasis: A pilot clinical investigation and animal validation."JOURNAL OF ETHNOPHARMACOLOGY.2024 Apr;323:117662

• 25. [IF=3.024] Xuan Yu et al."An innovative extraction strategy for herbal medicine by adopting p-sulphonatocalix[6]/[8]arenes."PHYTOCHEMICAL ANALYSIS

• 24. [IF=1.978] Chen Ming-jun et al."Composite Sophora Colon-Soluble Capsule Ameliorates DSS-Induced Ulcerative Colitis in Mice via Gut Microbiota-Derived Butyric Acid and NCR+ ILC3."Chin J Integr Med. 2022 Apr;:1-10

• 23. [IF=3.996] Wang Wen-Jun et al."Oxymatrine Alleviates Hyperglycemic Cerebral Ischemia/Reperfusion Injury via Protecting Microvessel."Neurochem Res. 2022 Jan;:1-14

• 22. [IF=4.268] Qing Zhao et al."The water extract of Sophorae tonkinensis Radix et Rhizoma alleviates non-alcoholic fatty liver disease and its mechanism."Phytomedicine. 2020 Oct;77:153270

• 21. [IF=9.229] Linlin Deng et al."Highly Crystalline Covalent Organic Frameworks Act as a Dual-Functional Fluorescent-Sensing Platform for Myricetin and Water, and Adsorbents for Myricetin."Acs Appl Mater Inter. 2021;13(28):33449–33463

• 20. [IF=11.622] Zheng Chunli et al."Systems pharmacology: a combination strategy for improving efficacy of PD-1/PD-L1 blockade."Brief Bioinform. 2021 Sep;22(5):

• 19. [IF=3.212] Gao Chun-Jie et al."Oxymatrine Sensitizes the HaCaT Cells to the IFN-γ Pathway and Downregulates MDC, ICAM-1, and SOCS1 by Activating p38, JNK, and Akt."Inflammation. 2018 Mar;41(2):606-613

• 18. [IF=4.087] Lan-Lan Lou et al."(+)‐Isobicyclogermacrenal and spathulenol from Aristolochia yunnanensis alleviate cardiac fibrosis by inhibiting transforming growth factor β/small mother against decapentaplegic signaling pathway."Phytother Res. 2019 Jan;33(1):214-223

• 17. [IF=4.411] Jifeng Gu et al."Application of High-Performance Liquid Chromatography Coupled with Linear Ion Trap Quadrupole Orbitrap Mass Spectrometry for Qualitative and Quantitative Assessment of Shejin-Liyan Granule Supplements."Molecules. 2018 Apr;23(4):884

• 16. Valkó, Klára. "Application of high-performance liquid chromatography based measurements of lipophilicity to model biological distribution." Journal of chromatography A 1037.1-2 (2004): 299-310.https://doi.org/10.1016/j.chroma.2003.10.084

• 15. Valkó, Klára. "Application of high-performance liquid chromatography based measurements of lipophilicity to model biological distribution." Journal of chromatography A 1037.1-2 (2004): 299-310.https://doi.org/10.1016/j.chroma.2003.10.084

• 14. 張偉 馬桂芝 王春芳 等. 一測多評法測定銀屑配方顆粒中4種生物堿的含量[J]. 西北藥學(xué)雜志 2018(5):595-600.

• 13. 王玲 張婷 錢大瑋 等. 3種辛味中藥揮發(fā)油對苦參生物堿類成分透皮吸收的影響[J]. 中國中藥雜志 2019 v.44(02):110-115.

• 12. 冉鑫, 呂順忠, 滕亮,等. 蒙藥壯格倫-5散劑的定性鑒別及含量測定[J]. 西北藥學(xué)雜志, 2019, 034(006):731-735.

• 11. 孫牧笛,胡麗杰,李文學(xué),閆思遠(yuǎn),張眾,顧沛雯.苦豆子內(nèi)生真菌誘導(dǎo)子促進宿主生物堿合成積累的生理防衛(wèi)反應(yīng)[J].干旱地區(qū)農(nóng)業(yè)研究,2019,37(03):60-65+71.

• 10. 孫牧笛, 張慶宸, 胡麗杰,等. 苦豆子內(nèi)生真菌誘導(dǎo)子促進宿主生物堿合成關(guān)鍵酶基因表達的熒光定量PCR檢測[J]. 中草藥 2018年49卷19期, 4621-4627頁, ISTIC PKU CSCD CA, 2018.

• 9. 安琪, 唐雪陽, 盧廣英,等. 紫蘇方藥物制備物的質(zhì)量表征及其關(guān)聯(lián)分析[J]. 北京中醫(yī)藥大學(xué)學(xué)報, 2014.

• 8. 段章好, 陳新梅, 郭輝. 氧化苦參堿磷脂復(fù)合物腸溶緩釋膠囊的質(zhì)量標(biāo)準(zhǔn)研究[J]. 山東中醫(yī)藥大學(xué)學(xué)報, 2018, 042(002):179-181.

• 7. 郭輝, 陳新梅, 段章好. 氧化苦參堿磷脂復(fù)合物腸溶緩釋膠囊在小鼠體內(nèi)的藥代動力學(xué)及相對生物利用度研究[J]. 山東中醫(yī)藥大學(xué)學(xué)報, 2017, 041(005):482-485.

• 6. 郝彩芹, 李靜, 李興玉,等. 氧化苦參堿對骨髓來源細(xì)胞生長的雙向調(diào)節(jié)作用[J]. 現(xiàn)代生物醫(yī)學(xué)進展, 2013, 13(021):4016-4022.

• 5. 龍興云, 張平, 歐立文. 氧化苦參堿對哮喘大鼠肺組織中IL-17表達的影響[J]. 湘南學(xué)院學(xué)報(醫(yī)學(xué)版), 2019.

• 4. 龍興云, 張平, 劉艷豐,等. 氧化苦參堿對哮喘大鼠肺組織IL-10表達的影響[J]. 現(xiàn)代生物醫(yī)學(xué)進展, 2016, 16(016):3036-3039.

• 3. 侯善群, 盧平, 鐘小健,等. 氧化苦參堿對哮喘大鼠氣道中IL-10和IL-17表達的影響[J]. 湘南學(xué)院學(xué)報(醫(yī)學(xué)版), 2017, 02(v.23;No.463):17-20.

• 2. 陳新梅, 趙元, 郭輝. 外翻腸囊法研究氧化苦參堿磷脂復(fù)合物的腸吸收特性[J]. 中國現(xiàn)代應(yīng)用藥學(xué), 2019, v.36(08):50-54.

• 1. 夏藝 毛芬蘭 向蘇 等. HPLC法測定酒炙苦參中三種生物堿的含量[J]. 中國藥師 2018(1):146-148.

輸入產(chǎn)品批號：

本計算器可幫助您計算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系，公式為：

質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)

• pg ng μg mg g kg =
  fM pM nM μM mM M *
  nL μL mL L *